You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hormone refractory

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))

Terminated
  • Refractory Cancer
  • BIBW 2992 (Afatinib)
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Jun 29, 2022

Hormone-refractory Prostate Cancer Trial (AMX-500)

Not yet recruiting
  • Hormone-refractory Prostate Cancer
  • (no location specified)
Aug 11, 2023

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Sinusitis Trial in Beijing (Mometasone furoate nasal spray hormone, Mometasone furoate nasal spray hormone + oral hormone,

Recruiting
  • Sinusitis
  • Mometasone furoate nasal spray hormone
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
May 21, 2022

Prostate Cancer Trial in United States (Vinflunine)

Completed
Has Results
  • Prostate Cancer
  • Fort Myers, Florida
  • +11 more
Dec 14, 2021

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
Jan 17, 2022

Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the

Completed
Has Results
  • Triple Negative Breast Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 17, 2021

Hormone Refractory Prostate Cancer Trial in United States (Docetaxel, TroVax)

Terminated
  • Hormone Refractory Prostate Cancer
  • San Bernardino, California
  • +6 more
Oct 8, 2020

Hormone Refractory Prostate Cancer Trial in United States (LBH589)

Terminated
  • Hormone Refractory Prostate Cancer
  • Boston, Massachusetts
  • +4 more
Dec 16, 2020

Prostate Cancer Trial in Canada, United States (LBH589 (i.v. panobinostat))

Completed
  • Prostate Cancer
  • LBH589 (i.v. panobinostat)
  • Rockville, Maryland
  • +8 more
Dec 16, 2020

Gout Trial in Shanghai (Adrenocorticotropic Hormone, Methylprednisolone Injection)

Recruiting
  • Gout
  • Adrenocorticotropic Hormone
  • Methylprednisolone Injection
  • Shanghai, Shanghai, China
    Shanghai Tenth People's hospital
Mar 19, 2021

Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)

Completed
  • Hormone Refractory Prostate Cancer
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Prostate Cancer Trial in Omaha (HyperAcute-Prostate Cancer Vaccine)

Completed
  • Prostate Cancer
  • HyperAcute-Prostate Cancer Vaccine
  • Omaha, Nebraska
    University of Nebraska Medical Center
May 26, 2020

Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
Apr 30, 2021

Metastatic Hormone Refractory Prostate Cancer Trial in Worldwide (Patupilone, prednisone, docetaxel)

Completed
  • Metastatic Hormone Refractory Prostate Cancer
  • La Jolla, California
  • +31 more
Dec 11, 2020

Prostate Cancer Trial in Los Angeles (carboplatin, paclitaxel)

Completed
Has Results
  • Prostate Cancer
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Aug 17, 2020

Prostate Cancer Trial in Canada (GTI-2040, docetaxel, prednisone)

Completed
  • Prostate Cancer
  • GTI-2040
  • +2 more
  • Vancouver, British Columbia, Canada
  • +4 more
Apr 23, 2021

Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)

Terminated
  • Prostatic Neoplasms
  • London, Ontario, Canada
  • +2 more
May 5, 2020

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,

Unknown status
Has Results
  • Estrogen Receptor Negative
  • +9 more
  • Chicago, Illinois
  • +1 more
Jun 25, 2020

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Completed
  • Metastatic Cancer
  • Prostate Cancer
  • Dublin, Ireland
  • +4 more
Nov 16, 2020

Prostate Carcinoma Metastatic to the Bone, Stage IV Prostate Adenocarcinoma, Hormone-refractory Prostate Cancer Trial in United

Active, not recruiting
  • Prostate Carcinoma Metastatic to the Bone
  • +2 more
  • Birmingham, Alabama
  • +5 more
Feb 10, 2021

Prostate Cancer Trial in Calgary, Toronto (gefitinib)

Completed
  • Prostate Cancer
  • Calgary, Alberta, Canada
  • +1 more
Apr 2, 2020